BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36006515)

  • 1. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia.
    Sekine R; Menzel S; Hähner A; Mori E; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).
    Liu DT; Welge-Lüssen A; Besser G; Mueller CA; Renner B
    Sci Rep; 2020 Oct; 10(1):18019. PubMed ID: 33093474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthonasal and retronasal odor identification in patients with parosmia.
    Li S; Boscolo-Rizzo P; Uderzo F; Tirelli G; Whitcroft KL; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4933-4938. PubMed ID: 37338584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Jul; 134(7):3277-3285. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.
    Altundag A; Yilmaz E; Kesimli MC
    Laryngoscope; 2022 Jul; 132(7):1433-1438. PubMed ID: 35257391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A parosmia severity index based on word-classification predicts olfactory abilities and impairment.
    Hörberg T; Sekine R; Overbeck C; Hummel T; Olofsson JK
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3695-3706. PubMed ID: 36906652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trigeminal function in patients with COVID-associated olfactory loss.
    Juratli JH; Garefis K; Konstantinidis I; Hummel T
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
    Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
    Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent olfactory dysfunction in mild COVID-19 patients: A descriptive study of the characteristics and association with other symptoms.
    García-Meléndez DD; Morales-Casado MI; Quintana Castro P; Marsal Alonso C
    Med Clin (Barc); 2023 Apr; 160(8):347-351. PubMed ID: 36670030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and assessment of qualitative olfactory dysfunction in different age groups.
    Nordin S; Murphy C; Davidson TM; Quiñonez C; Jalowayski AA; Ellison DW
    Laryngoscope; 1996 Jun; 106(6):739-44. PubMed ID: 8656960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients.
    Cancellieri E; Hernandez AK; Degkwitz H; Kahre E; Blankenburg J; Horst TS; Czyborra P; Boscolo-Rizzo P; Hummel T
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the clinical usefulness of structured questions in parosmia assessment.
    Landis BN; Frasnelli J; Croy I; Hummel T
    Laryngoscope; 2010 Aug; 120(8):1707-13. PubMed ID: 20641087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of the Parosmia Olfactory Dysfunction Outcomes Rating (DisODOR).
    Ioerger P; Kallogjeri D; Roland L; Schneider JS; Piccirillo JF; Farrell NF
    Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1654-1661. PubMed ID: 37622602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections.
    Menzel S; Haehner A; Woosch D; Marquardt B; Ressel C; Draf J; Ottaviano G; Boscolo-Rizzo P; Kardashi R; de With K; Hackl Y; Hummel T
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2331-2340. PubMed ID: 36547711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.